| Cash flow (USD) | Q4 2026 ended Jun 30, 2026 | Q3 2026 ended Mar 31, 2026 | Q2 2026 ended Dec 31, 2025 | Q1 2026 ended Sep 30, 2025 | Q4 2025 ended Jun 30, 2025 | Q3 2025 ended Mar 31, 2025 | Q2 2025 ended Dec 31, 2024 | Q1 2025 ended Sep 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Net income | -2.49M | -3.88M | -6.52M | -6.41M | -31.60M | -3.97M | -5.89M | -5.42M |
| Depreciation and amortization | 50.0K | 65.0K | 59.0K | 66.0K | 61.0K | -5.0K | 200.0K | 64.0K |
| Stock-based compensation | 1.19M | -1.47M | -2.28M | 2.63M | 1.30M | -416.0K | -435.0K | 459.0K |
| Cash from operations | 3.37M | -2.46M | -4.62M | -9.16M | -1.48M | -3.16M | -5.63M | -2.25M |
| Capital expenditure | 1.0K | -5.0K | -4.0K | -2.0K | 0 | 0 | ||
| Free cash flow | 3.38M | -2.46M | -4.63M | -9.16M | -1.48M | -3.16M | ||
| Cash from investing | -30.0K | -18.0K | -4.0K | -42.0K | 0 | 0 | ||
| Share buybacks | -7.08M | -1.14M | ||||||
| Net debt issued | 2.88B | |||||||
| Cash from financing | -6.91M | 4.71M | 927.0K | 67.18M | 9.60M | 7.74M | 4.10M | -52.0K |
| Net change in cash | -3.57M | 2.24M | -3.70M | 57.97M | 8.12M | 4.58M | -1.60M | -2.23M |
From Incannex Healthcare Inc.'s 10-K and 10-Q filings with the SEC. Fourth quarters, and quarters where the company only reported year-to-date totals, are worked out by subtracting the earlier quarters. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read cash flow or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.